Skip to main content
Equibles
BIIB logo

BIIB · Biogen Inc.

Track BIIB — free

Use BIIB with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$224.92 +8.88 (+4.11%)
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$31.99B
Shares
147.64M

BIIB metrics

81 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$216.04
Market cap
$31.99B

Price action

19 metrics
Price change (1W)
-2.1%
Price change (30D)
+7.0%
Price change (3M)
+14.4%
Price change (6M)
+17.4%
Price change (YTD)
+22.8%
Price change (1Y)
+63.4%
Trailing year
Price change (5Y)
-36.1%
52-week high
$221.56
52-week low
$135.67
Change from 52-week high
-2.5%
Change from 52-week low
+59.2%
Annualized volatility
35.0%
Beta
0.4
RSI (14D)
54.8
Price vs SMA 50
+3.8%
Price vs SMA 200
+13.6%
Avg volume (3M)
1.12M
Relative volume
0.7
Average dollar volume
$229.52M

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - General
Shares outstanding
147.64M

Valuation

12 metrics
P / E (TTM)
23.2
Trailing earnings · reciprocal yield 4.3%
PEG ratio
0.7
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
3.2×
reciprocal yield 31.1%
P / book
1.7
reciprocal yield 58.3%
FCF yield
7.6%
TTM · current market cap
Buyback yield
—
P / FCF
13.2
reciprocal yield 7.6%
P / operating cash flow
12.3
reciprocal yield 8.1%
Earnings yield
4.3%

Historical valuation

8 metrics
P / E historical average (3Y)
17.5×
reciprocal yield 5.7%
P / E historical average (5Y)
17.9×
reciprocal yield 5.6%
EV / revenue historical average (3Y)
3.1×
reciprocal yield 31.8%
EV / revenue historical average (5Y)
3.4×
reciprocal yield 29.1%
EV / EBIT historical average (3Y)
13.7×
reciprocal yield 7.3%
EV / EBIT historical average (5Y)
13.3×
reciprocal yield 7.5%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-01

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
13.8%
Gross profit (TTM)
$11.64B
Operating profit (TTM)
$2.48B
Net income (TTM)
$1.37B
Trailing 12 months
Diluted EPS (TTM)
$9.30
FCF margin
24.4%
Effective tax rate
15.5%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
$72.08
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$20.16

Growth

11 metrics
Revenue growth YoY
+1.9%
Year over year
Net income growth YoY
+32.8%
Revenue (TTM)
$9.94B
Trailing 12 months
EPS growth YoY
+31.1%
Shares change YoY
+1.2%
Year over year · more shares
Revenue CAGR (3Y)
-0.9%
Revenue CAGR (5Y)
-6.0%
EPS CAGR (3Y)
-25.0%
EPS CAGR (5Y)
-18.7%
FCF CAGR (3Y)
+21.5%
FCF CAGR (5Y)
-11.6%

Quality

14 metrics
Return on equity
7.4%
Return on assets
4.7%
Debt / equity
—
Current ratio
3.1
EBITDA (TTM)
$3.01B
Free cash flow (TTM)
$2.42B
Quick ratio
2.4
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$3.38B
Total assets
$29.48B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$2.59B
Capital expenditures (TTM)
$167.90M
R&D (TTM)
$1.88B
SG&A (TTM)
$2.47B
Stock compensation (TTM)
$293.80M
R&D / revenue
19.0%
Stock compensation / revenue
3.0%

Ownership (13F)

3 metrics
13F filers
1,045
13F filer change QoQ
+27
Institutional ownership
99.5%

Short interest

3 metrics
Short interest
3.5%
Latest settlement · 6.1 days to cover
Days to cover
6.1d
Short-squeeze score
58 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$239,750
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 875045 CUSIP 09062X103 13F (30d) 677 filings 648 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)